CD4 and COVID-19: In this context, using multiple experimental approaches, SARS-CoV-2-specific CD4+ and CD8+ T lymphocytes against structural and non-structural regions were observed in all COVID-19 cases, even among antibody-seronegative asymptomatic and mild COVID-19 cases (19, 20).